The effects of inducing agents on the metabolism of pentamidine by isolated rat hepatocytes

C. Atsriku, M.H. Grant, G.G. Skellern, D.G. Watson

Research output: Contribution to journalArticle

Abstract

Abstract of toxicology paper. The aromatic diamidine, pentamidine isethionate, has been used for over four decades for the chemotherapy of African human trypanosomiasis (sleeping sickness) in affected areas world-wide (Goa and Campoli-Richards, 1987). Pentamidine (P) is also used for the treatment of Pneumocyctis carinii pneumonia commonly associated with AIDS victims and over 45% of patients who receive the drug are known to suffer severe adverse reactions (Sands et al., 1985). However, emergence of drug resistant strains of trypanosomes has become a major barrier to the efficacy of trypanocidal diamidines (Peregrine, 1994). In view of poor prospects for new drug development, attempts to sustain efficacy of the drug have focussed on research into the causes of parasite drug resistance as well as drug toxicity. The inhibition or induction of hepatic drug metabolising enzymes following multiple drug therapy or exposure to environmental chemicals can alter the metabolism profile and pharmacokinetics of a given drug, leading to either a toxicological response or therapeutic failure. The aim of this study was to investigate the effects of two classical cytochrome P450 inducers, phenobarbitone (PB) and 3-methylcholanthrene (3MC), as well as a pyrethroid insecticide, deltamethrin (DM), on the metabolism of P by isolated rat hepatocytes.
LanguageEnglish
Pages234-235
Number of pages1
JournalToxicology
Volume194
Issue number3
DOIs
Publication statusPublished - 2004

Fingerprint

Pentamidine
Metabolism
Rats
Hepatocytes
Pharmaceutical Preparations
Toxicology
Implosive Therapy
African Trypanosomiasis
Pyrethrins
Methylcholanthrene
Trypanosomiasis
Environmental Exposure
Pharmacokinetics
Phenobarbital
Chemotherapy
Insecticides
Drug-Related Side Effects and Adverse Reactions
Cytochrome P-450 Enzyme System
Pneumonia
Parasites

Keywords

  • pentamidine
  • diminazene
  • inducing agents
  • hepatocytes
  • liquid chromatography-electrospray
  • ionisation
  • mass spectrometry

Cite this

Atsriku, C. ; Grant, M.H. ; Skellern, G.G. ; Watson, D.G. / The effects of inducing agents on the metabolism of pentamidine by isolated rat hepatocytes. In: Toxicology. 2004 ; Vol. 194, No. 3. pp. 234-235.
@article{ba9cd516cba84e4aa2c920088433edc8,
title = "The effects of inducing agents on the metabolism of pentamidine by isolated rat hepatocytes",
abstract = "Abstract of toxicology paper. The aromatic diamidine, pentamidine isethionate, has been used for over four decades for the chemotherapy of African human trypanosomiasis (sleeping sickness) in affected areas world-wide (Goa and Campoli-Richards, 1987). Pentamidine (P) is also used for the treatment of Pneumocyctis carinii pneumonia commonly associated with AIDS victims and over 45{\%} of patients who receive the drug are known to suffer severe adverse reactions (Sands et al., 1985). However, emergence of drug resistant strains of trypanosomes has become a major barrier to the efficacy of trypanocidal diamidines (Peregrine, 1994). In view of poor prospects for new drug development, attempts to sustain efficacy of the drug have focussed on research into the causes of parasite drug resistance as well as drug toxicity. The inhibition or induction of hepatic drug metabolising enzymes following multiple drug therapy or exposure to environmental chemicals can alter the metabolism profile and pharmacokinetics of a given drug, leading to either a toxicological response or therapeutic failure. The aim of this study was to investigate the effects of two classical cytochrome P450 inducers, phenobarbitone (PB) and 3-methylcholanthrene (3MC), as well as a pyrethroid insecticide, deltamethrin (DM), on the metabolism of P by isolated rat hepatocytes.",
keywords = "pentamidine, diminazene, inducing agents, hepatocytes, liquid chromatography-electrospray, ionisation, mass spectrometry",
author = "C. Atsriku and M.H. Grant and G.G. Skellern and D.G. Watson",
year = "2004",
doi = "10.1016/j.tox.2003.09.003",
language = "English",
volume = "194",
pages = "234--235",
journal = "Toxicology",
issn = "0300-483X",
number = "3",

}

The effects of inducing agents on the metabolism of pentamidine by isolated rat hepatocytes. / Atsriku, C.; Grant, M.H.; Skellern, G.G.; Watson, D.G.

In: Toxicology, Vol. 194, No. 3, 2004, p. 234-235.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effects of inducing agents on the metabolism of pentamidine by isolated rat hepatocytes

AU - Atsriku, C.

AU - Grant, M.H.

AU - Skellern, G.G.

AU - Watson, D.G.

PY - 2004

Y1 - 2004

N2 - Abstract of toxicology paper. The aromatic diamidine, pentamidine isethionate, has been used for over four decades for the chemotherapy of African human trypanosomiasis (sleeping sickness) in affected areas world-wide (Goa and Campoli-Richards, 1987). Pentamidine (P) is also used for the treatment of Pneumocyctis carinii pneumonia commonly associated with AIDS victims and over 45% of patients who receive the drug are known to suffer severe adverse reactions (Sands et al., 1985). However, emergence of drug resistant strains of trypanosomes has become a major barrier to the efficacy of trypanocidal diamidines (Peregrine, 1994). In view of poor prospects for new drug development, attempts to sustain efficacy of the drug have focussed on research into the causes of parasite drug resistance as well as drug toxicity. The inhibition or induction of hepatic drug metabolising enzymes following multiple drug therapy or exposure to environmental chemicals can alter the metabolism profile and pharmacokinetics of a given drug, leading to either a toxicological response or therapeutic failure. The aim of this study was to investigate the effects of two classical cytochrome P450 inducers, phenobarbitone (PB) and 3-methylcholanthrene (3MC), as well as a pyrethroid insecticide, deltamethrin (DM), on the metabolism of P by isolated rat hepatocytes.

AB - Abstract of toxicology paper. The aromatic diamidine, pentamidine isethionate, has been used for over four decades for the chemotherapy of African human trypanosomiasis (sleeping sickness) in affected areas world-wide (Goa and Campoli-Richards, 1987). Pentamidine (P) is also used for the treatment of Pneumocyctis carinii pneumonia commonly associated with AIDS victims and over 45% of patients who receive the drug are known to suffer severe adverse reactions (Sands et al., 1985). However, emergence of drug resistant strains of trypanosomes has become a major barrier to the efficacy of trypanocidal diamidines (Peregrine, 1994). In view of poor prospects for new drug development, attempts to sustain efficacy of the drug have focussed on research into the causes of parasite drug resistance as well as drug toxicity. The inhibition or induction of hepatic drug metabolising enzymes following multiple drug therapy or exposure to environmental chemicals can alter the metabolism profile and pharmacokinetics of a given drug, leading to either a toxicological response or therapeutic failure. The aim of this study was to investigate the effects of two classical cytochrome P450 inducers, phenobarbitone (PB) and 3-methylcholanthrene (3MC), as well as a pyrethroid insecticide, deltamethrin (DM), on the metabolism of P by isolated rat hepatocytes.

KW - pentamidine

KW - diminazene

KW - inducing agents

KW - hepatocytes

KW - liquid chromatography-electrospray

KW - ionisation

KW - mass spectrometry

U2 - 10.1016/j.tox.2003.09.003

DO - 10.1016/j.tox.2003.09.003

M3 - Article

VL - 194

SP - 234

EP - 235

JO - Toxicology

T2 - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 3

ER -